Lot-to-lot consistency study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants from 2 Months of Age

Trial Identifier: PSK00029
Sponsor: Sanofi
Start Date: January 2026
Primary Completion Date: June 2027
Study Completion Date: May 2028
Condition: Healthy Volunteers; Pneumococcal Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
HONDURAS San Pedro Sula, HONDURAS, 21104
HONDURAS Tegucigalpa, HONDURAS, 11101
PUERTO RICO San Juan, PUERTO RICO, 00918
PUERTO RICO, Puerto Rico Guayama, Puerto Rico, PUERTO RICO, 00786
PUERTO RICO, Puerto Rico Trujillo Alto, Puerto Rico, PUERTO RICO, 00976
United States, Florida Tampa, Florida, United States, 33613
United States, Kentucky Bardstown, Kentucky, United States, 40004
United States, Texas Edinburg, Texas, United States, 78539
UNITED STATES, Arkansas Fayetteville, Arkansas, UNITED STATES, 72703
UNITED STATES, California Huntington Park, California, UNITED STATES, 90255
UNITED STATES, California Los Angeles, California, UNITED STATES, 90008
UNITED STATES, California Los Angeles, California, UNITED STATES, 90057
UNITED STATES, Michigan Allen Park, Michigan, UNITED STATES, 48101
UNITED STATES, South Carolina Charleston, South Carolina, UNITED STATES, 29407
UNITED STATES, South Carolina Simpsonville, South Carolina, UNITED STATES, 29681
UNITED STATES, South Carolina Spartanburg, South Carolina, UNITED STATES, 29301
UNITED STATES, Texas Richmond, Texas, UNITED STATES, 77469
UNITED STATES, Utah Ogden, Utah, UNITED STATES, 84404